Učitavanje...
A gonadotropin-releasing hormone antagonist reduces serum adrenal androgen levels in prostate cancer patients
BACKGROUND: Adrenal androgens play an important role in the development of castration-resistant prostate cancer therapeutics. The effect of gonadotropin-releasing hormone (GnRH) antagonists on adrenal androgens has not been studied sufficiently. We measured testicular and adrenal androgen levels in...
Spremljeno u:
| Izdano u: | BMC Urol |
|---|---|
| Glavni autori: | , , , , , , , , |
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
BioMed Central
2017
|
| Teme: | |
| Online pristup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5575925/ https://ncbi.nlm.nih.gov/pubmed/28851333 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12894-017-0261-z |
| Oznake: |
Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!
|